Skip to Main Content
Menu Button
About Alkeus
Our science
Disease areas
Patients
News
Careers
News
View All
View All
Press Releases
Publications
Icon
Search for:
FDA Grants Alkeus Pharmaceuticals Breakthrough Therapy Designation for ALK-001 (C20-D3-vitamin A) for the Treatment of Stargardt Disease
July 14, 2021
Learn more
1
2
3
4